Last reviewed · How we verify
NCT04587609
Reducing Cell Phone Use While Driving Among High Risk UBI Auto Policy Holders
NA trial testing Free Phone Mounts in Distracted Driving in 1,668 participants. Completed in 30 June 2021.
23 May 2021
Quick facts
| Lead sponsor | University of Pennsylvania |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 1,668 |
| Start date | 1 March 2021 |
| Primary completion | 23 May 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Free Phone Mounts
- Commitment Contract
- Personalized Habit Tips
- Social Gamification Feedback
- "Contest" Financial Incentives
Conditions studied
- Distracted Driving — all drugs for Distracted Driving →
- Driving Impaired — all drugs for Driving Impaired →
Sponsor
University of Pennsylvania
Who can join
18 and older, any sex, with Distracted Driving or Driving Impaired. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Insurance User Based Insurance (UBI) users will be invited to participate in a randomized control trial where they will be randomized into 1 of 4 arms: (Arm 1) standard UBI, (Arm 2) Standard UBI + Free phone mounts (Arm 3) Commitment + Habit Tips, (Arm 4) Gamification + Social Competition,(Arm 5) Contest Financial Incentives. Each successive arm will experience all of the elements that the lower-numbered arms will.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A randomized trial of behavioral interventions yielding sustained reductions in distracted driving.
Ebert JP, Xiong RA, Khan N, Abdel-Rahman D, et al · · 2024 · cited 5× · PMID 39074277 · DOI 10.1073/pnas.2320603121 -
Validation of a smartphone telematics algorithm for classifying driver trips.
Ebert JP, Xiong RA, Patel A, Abdel-Rahman D, et al · · 2024 · cited 1× · PMID 40927251 · DOI 10.1016/j.trip.2024.101109
Verify or expand the search:
- PubMed search for NCT04587609
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Pennsylvania trials
Trials by the same sponsor.
- NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
- NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
- NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
- NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
- NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04587609 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
- Last refreshed: 2 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04587609.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing